Why Attend

Agenda

Location & CLE

Monday, June 5

10:00–11:15 AM 
FDLI Welcome and First Session

FDLI Welcome and Announcements
Bianca Cardona Melendez, Assistant Director, Educational Programs, FDLI

I. A Look Back: The History of Cannabis Regulation
Seth Gitner, Associate, Saul Ewing LLP

In this session, the speaker will explore the evolution of cannabis regulation in the United States, discuss terms and definitions, historical uses, and distinguish between Hemp vs. Marijuana, Synthetic vs. Natural, and Intoxicating vs. Non-Intoxicating and Cannabis Medical uses. Speakers will also examine key legislation, such as the Marijuana Tax Act of 1937, which significantly impacted the legal status of cannabis, and discuss federal enforcement discretion.

11:25 AM–12:15 PM     
Post-2018 Cannabis Industry and Regulation
Thomas Berry, Senior Vice President, Regulatory Compliance, Greenleaf Health, Inc.

This session will explore post-2018 cannabis key legislation such as the 2018 Farm Bill, the 2022 USDA Hemp Report, and the Marijuana Opportunity Reinvestment and Expungement (MORE) Act. The speaker will also discuss the regulatory landscape for CBD products and state efforts to regulate the cannabis market and industrial hemp.

12:15–1:00 PM
Break

1:00–1:30 PM
III.  Impacts of Cannabis Legalization
Gillian L. Schauer, Executive Director, Cannabis Regulators Association

This session will explore the two decades of state legalization and federal inactivity and discuss the research on the health consequences of cannabis product use, such as the cost and benefits of cannabis control policies, Non-Intoxicating Cannabinoids, discuss the Medical Cannabis Legalization and Adult-Use Cannabis. The speaker will also discuss tracking the public health impacts of Cannabis Legalization at the state level.

1:40–2:30 PM
IV. Research, Quality, and Litigation
David Kouba, Counsel, Arnold & Porter
Deborah Miran, Principal, DMiran Consulting

This session will explore the latest trends and challenges in research on marijuana and the cannabis industry. The speakers will provide insights into the current state of research and quality control; practices and improved access to cannabis for research and recent studies. This session will also explore litigation on Cannabis issues, product liability, and false advertising.

2:45–3:35 PM
V. Hot Topics and Current Issues Panel Discussion
Thomas R. Berry, Senior Vice President, Regulatory Compliance, Greenleaf Health, Inc.
Seth Gitner, Associate, Saul Ewing LLP
Moderated by Deborah Miran, Principal, DMiran Consulting

In this session, speakers will discuss current topics such as the 2022 Farm Bill, Banking Bill; Biden’s Administration’s move to reexamine the scheduling of Cannabis Products; CBD; FDA Inspections of Retail Establishments; World Health Organization (WHO) Review of Cannabis and Cannabis-Related Substances and Potential Federal Legislation and Pathways to Market.

3:35 PM
Adjournment